153
Views
2
CrossRef citations to date
0
Altmetric
Comorbidities

Characteristics of lower airway inflammatory changes in the minimal persistent inflammation of allergic rhinitis in mice

, PhD, , MD, , MD, , MD, , MD, , MD, , PhD, , PhD & , PhD show all
Pages 1187-1196 | Received 10 May 2017, Accepted 25 Nov 2017, Published online: 26 Dec 2017

References

  • Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, et al. Allergic rhinitis and its impact on asthma (ARIA) 2008 [J]. Allergy. 2008;63(s86):8–160. doi:10.1111/j.1398-9995.2007.01620.x.
  • Global Strategy for Asthma Management and Prevention. Global Initiative for Asthma; 2011 [accessed 2017 May 10]. http://www.ginasthma.org.
  • Ciprandi G, Buscaglia S, Pesce G, Pronzato C, Ricca V, Parmiani S, Bagnasco M, Canonica GW. Minimal persistent inflammation is present at mucosal level in patients with asymptomatic rhinitis and mite allergy [J]. J Allergy Clin Immunol 1995;96(6):971–9. doi:10.1016/S0091-6749(95)70235-0.
  • Ricca V, Landi M, Ferrero P, Bairo A, Tazzer C, Canonica GW, Ciprandi G. Minimal persistent inflammation is also present in patients with seasonal allergic rhinitis [J]. J Allergy Clin Immunol 2000;105(1):54–7. doi:10.1016/S0091-6749(00)90177-5.
  • Canonica GW, Compalati E. 2009 Minimal persistent inflammation in allergic rhinitis: implications for current treatment strategies [J]. Clin Exp Immunol;158(3):260–71. doi:10.1111/j.1365-2249.2009.04017.x.
  • Storms WW. Minimal persistent inflammation, an emerging concept in the nature and treatment of allergic rhinitis; the possible role of leukotrienes [J]. Ann Allergy Asthma Immunol 2003;91(2):131–40. doi:10.1016/S1081-1206(10)62167-9.
  • Lei F, Zhu D, Sun J, Dong Z. Effects of minimal persistent inflammation on nasal mucosa of experimental allergic rhinitis [J]. Am J Rhinol Allergy 2010;24(1):e23–8. doi:10.2500/ajra.2010.24.3414.
  • McCusker C, Chicoine M, Hamid Q, Mazer B. Site-specific sensitization in a murine model of allergic rhinitis: role of the upper airway in lower airways disease [J]. J Allergy Clin Immunol 2002;110(6):891–8. doi:10.1067/mai.2002.130048.
  • Chen S, Wang Y, Gong G, Chen J, Niu Y, Kong W. Ethyl pyruvate attenuates murine allergic rhinitis partly by decreasing high mobility group box 1 release. Exp Biol Med 2015,240(11):1490–9 doi:10.1177/1535370214566563.
  • Chapman DG, Tully JE, Nolin JD, Janssen-Heininger YM, Irvin CG. Animal models of allergic airways disease: Where are we and where to next? [J]. J Cell Biochem 2014;115(12):2055–64. doi:10.1002/jcb.24881.
  • McCusker C, Chicoine M, Hamid Q, Mazer BJ. Site-specific sensitization in a murine model of allergic rhinitis: role of the upper airway in lower airways disease. Allergy Clin Immunol 2002;110(6):891–8. doi:10.1067/mai.2002.130048.
  • Hellings PW, Hessel EM, Van Den Oord JJ, Kasran A, Van Hecke P, Ceuppens JL. Eosinophilic rhinitis accompanies the development of lower airway inflammation and hyper-reactivity in sensitized mice exposed to aerosolized allergen. Clin Exp Allergy 2001;31(5):782–90. doi:10.1046/j.1365-2222.2001.01081.x.
  • Bradding P, Feather IH, Wilson S, Bardin PG, Heusser CH, Holgate ST, Howarth PH. Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. The mast cell as a source of IL-4, IL-5, and IL-6 in human allergic mucosal inflammation [J]. J Immunol 1993;151(7):3853–65.
  • Gour N, Wills-Karp M. IL-4 and IL-13 signaling in allergic airway disease [J]. Cytokine 2015;75(1):68–78. doi:10.1016/j.cyto.2015.05.014.
  • Sehmi R, Wood LJ, Watson R, Foley R, Hamid Q, O'Byrne PM, Denburg JA. Allergen-induced increases in IL-5 receptor alpha-subunit expression on bone marrow-derived CD34+ cells from asthmatic subjects. A novel marker of progenitor cell commitment towards eosinophilic differentiation [J]. J Clin Invest 1997;100(10):2466. doi:10.1172/JCI119789.
  • Skrindo I, Ballke C, Gran E, Johansen FE, Baekkevold ES, Jahnsen FL. IL‐5 production by resident mucosal allergen‐specific T cells in an explant model of allergic rhinitis [J]. Clin Exp Allergy 2015;45(8):1296–304. doi:10.1111/cea.12543.
  • Kasaian MT, Marquette K, Fish S, DeClercq C, Agostinelli R, Cook TA, Brennan A, Lee J, Fitz L, Brooks J, et al. An IL-4/IL-13 dual antagonist reduces lung inflammation, airway hyperresponsiveness, and IgE production in mice[J]. Am J Respir Cell Mol Biol 2013;49(1):37–46. doi:10.1165/rcmb.2012-0500OC.
  • Jatakanon A, Uasuf C, Maziak W, Lim S, Chung KF, Barnes PJ. Neutrophilic inflammation in severe persistent asthma[J]. Am J Respir Crit Care Med 1999;160(5):1532–9. doi:10.1164/ajrccm.160.5.9806170.
  • O'Byrne PM, Inman MD, Parameswaran K. The trials and tribulations of IL-5, eosinophils, and allergic asthma [J]. J Allergy Clin Immunol 2001;108(4):503–8. doi:10.1067/mai.2001.119149.
  • Monteiro M, Almeida CF, Agua-Doce A, Graca L. Induced IL-17-producing invariant NKT cells require activation in presence of TGF-β and IL-1β. J Immunol 2013;190(2):805–11 doi:10.4049/jimmunol.1201010.
  • Zhang L, Gao H, Yang T, Yang B, Jiang X, Wang L, Wang Q, Luo Z, Liu E, Fu Z. Infant 7-valent pneumococcal conjugate vaccine immunization alters young adulthood CD4+ T cell subsets in allergic airway disease mouse model[J]. Vaccine 2014;32(18):2079–85. doi:10.1016/j.vaccine.2014.02.013.
  • Katelaris CH. Allergic rhinitis and asthma: epidemiological evidence for the linkc [J]. Clin Exp Allergy Rev 2003;3(1):5–8. doi:10.1046/j.1472-9725.2003.00054.x.
  • Passalacqua G, Ciprandi G, Canonica GW. The nose-lung interaction in allergic rhinitis and asthma: united airways disease [J]. Curr Opin Allergy Clin Immunol 2001;1(1):7–13.
  • Corren J. Allergic rhinitis and asthma: how important is the link? [J]. J Allergy Clin Immunol 1997;99(2):S781–6. doi:10.1016/S0091-6749(97)70127-1.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.